Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MU vs MRNA✓SelectedUSD · MRNAMU vs MRNA performance historyLatest closeAs of-1.00%11/18
Stock and ETF performance explorer

MU vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,948.6%
MRNA return
+794.5%
Excess return
+1,154.1%
Maximum drawdown
-57.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.0%-4.8%+3.8%-0.6%
7D-13.1%-20.9%+7.8%-11.5%
30D-22.1%-13.3%-8.8%-21.3%
3M-25.0%+212.6%-237.6%-36.1%
6M+3.5%+309.0%-305.5%-15.5%
YTD+147.3%+567.3%-420.0%+89.0%
1Y+209.0%+689.7%-480.7%+131.5%
3Y+818.1%+157.4%+660.7%+649.4%
5Y+837.9%-21.7%+859.6%+707.3%
All+1,948.6%+794.5%+1,154.1%+1,537.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling